Summary by Moomoo AI
ARK Investment Management LLC, an investment adviser based in Delaware, United States, has filed an amended Schedule 13G with the United States Securities and Exchange Commission on January 29, 2024, indicating a significant ownership stake in Ginkgo Bioworks Holdings, Inc. The filing, which reflects the state of ownership as of December 31, 2023, reports that ARK Investment Management LLC has beneficial ownership of 198,606,619 shares of Ginkgo Bioworks' Class A Common Stock, representing 12.26% of the class. The shares are held in the ordinary course of business, with no intention of changing or influencing the control of the issuer. ARK Investment Management LLC possesses sole voting power over 189,683,331 shares and shared voting power over 5,064,553 shares, with sole dispositive power over the entire 198,606,619 shares reported.